**Transrectal Ultrasound Market Growth Drivers 2034**

According to Fortune Business Insights,The global transrectal ultrasound market size was valued at USD 271.11 million in 2025. The market is projected to grow from USD 287.97 million in 2026 to USD 489.64 million by 2034, exhibiting a CAGR of 6.90% during the forecast period. North America dominated the transrectal ultrasound market with a market share of 29.10% in 2025.

Continue reading for more details:

https://www.fortunebusinessinsights.com/industry-reports/transrectal-ultrasound-trus-market-100137

Market Segmentation
According to Fortune Business Insights, the Transrectal Ultrasound Market is segmented by product into systems and transducers, with transrectal ultrasound systems dominating due to increasing regulatory approvals and frequent new product launches meeting the growing diagnostic demand. By type, the market is divided into cart/trolley-based and portable transrectal ultrasound devices, where cart/trolley-based systems hold the largest share as they are widely used in hospitals and ambulatory surgical centers, while the portable segment gains traction due to the adoption of advanced handheld transrectal ultrasound tools. Based on application, the transrectal ultrasound market includes diagnostic (such as prostate cancer and benign prostatic hyperplasia) and image-guided treatment sub-segments, with diagnostic procedures contributing significantly to overall usage. Additionally, end-user segmentation includes hospitals & ASCs, diagnostic laboratories, and others, highlighting diverse adoption points for transrectal ultrasound technologies.

Key Players
BK Medical Holding Company, Inc.

KOELIS

Exact Imaging

Telemed Medical Systems

FUJIFILM Corporation

Strata Imaging

Market Growth
The transrectal ultrasound market is projected to grow substantially in 2026, with the global market size expected to reach approximately USD 287.97 million, expanding further toward long-term value growth through 2034 at a CAGR around 6.90%. Growth in the transrectal ultrasound market is primarily driven by the rising prevalence of prostate cancer worldwide, increased awareness of early diagnosis benefits, and strong reimbursement frameworks in key regions. Continuous technological developments in transrectal ultrasound devices, including enhancements in imaging capabilities and integration with advanced diagnostic tools, also bolster market expansion.

Restraining Factors
Despite the positive outlook, the transrectal ultrasound market faces challenges, including relatively high system costs that hinder adoption, especially in emerging economies, and limited reimbursement coverage in certain regions, which can deter smaller clinics and healthcare providers from investing in advanced transrectal ultrasound equipment. Additionally, a shortage of trained specialists for operating transrectal ultrasound systems may slow market growth in some areas.

Regional Analysis
Regionally, North America leads the transrectal ultrasound market, accounting for the largest share driven by high prostate cancer incidence rates, advanced healthcare infrastructure, and favorable reimbursement policies that support the adoption of transrectal ultrasound technologies. Europe follows with significant growth prospects due to initiatives promoting early cancer detection and regulatory approvals for innovative solutions. The Asia Pacific transrectal ultrasound market is also expanding as outdated systems are replaced with modern units and healthcare spending increases in countries like China and India; however, markets in Latin America and the Middle East & Africa show slower adoption due to limited awareness and lower out-of-pocket healthcare expenditure levels.